Lifecore biomedical, inc. (lfcr) shareholders may have been affected by fraud- levi & korsinsky investigates

New york, ny / accesswire / july 19, 2024 / levi & korsinsky notifies investors that it has commenced an investigation of lifecore biomedical, inc. ("lifecore") (nasdaq:lfcr) concerning possible violations of federal securities laws. lifecore announced on march 20, 2024, that its board of directors had concluded its review of strategic alternatives, in which it "unanimously concluded that the best way to maximize value for stockholders at this time is to continue executing on the company's standalone strategic plan.
LFCR Ratings Summary
LFCR Quant Ranking